Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest

被引:50
|
作者
Zerwekh, Joseph E.
Odvina, Clarita V.
Wuermser, Lisa-Ann
Pak, Charles Y. C.
机构
[1] Univ Texas, SW Med Ctr, Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA
来源
JOURNAL OF UROLOGY | 2007年 / 177卷 / 06期
关键词
weightlessness countermeasures; nephrolithiasis; bed rest;
D O I
10.1016/j.juro.2007.01.156
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Exposure to the microgravity environment of space increases the risk of kidney stone formation, particularly for calcium oxalate and uric acid stones. This study was performed to evaluate the efficacy of potassium alkali as potassium-magnesium citrate in reducing renal stone risk and bone turnover. Materials and Methods: This study was performed as a double-blind, placebo controlled trial. We studied 20 normocalciuric subjects randomized to either placebo or potassium-magnesium citrate (42 mEq potassium, 21 mEq magnesium, 63 mEq citrate per day) before and during 5 weeks of strict bed rest. The study was performed in the General Clinical Research Center and under a controlled dietary regimen composed of 100 mEq of sodium, 800 mg of calcium, 0.8 gm/kg animal protein and 2,200 kcal per day. Two 24-hour urine collections were obtained under oil each week for assessment of stone risk parameters and relative saturation of calcium oxalate, brushite and undissociated uric acid. Blood was also collected for determination of serum immunoreactive parathyroid hormone and vitamin D metabolites. Results: Bed rest promoted a rapid increase in urinary calcium excretion of approximately 50 ing per day in both groups. Despite this increase subjects treated with potassium-magnesium citrate demonstrated significant decreases in the relative saturation of calcium oxalate and in the concentration of undissociated uric acid compared to placebo. Immunoreactive parathyroid hormone, serum 1,25-dihydroxyvitamin D and intestinal calcium absorption all decreased in both groups with no difference in response between the 2 treatment arms. Conclusions: Provision of alkali as potassium-magnesium citrate is an effective countermeasure for the increased risk of renal stone disease associated with immobilization. Despite an increase in urine calcium concentration, the relative saturation of calcium oxalate decreased due to citrate chelation of calcium and the concentration of undissociated uric acid decreased due to the significant increase in urine pH.
引用
收藏
页码:2179 / 2184
页数:6
相关论文
共 10 条
  • [1] Reduction of microgravity-induced renal stone risk by potassium-magnesium citrate.
    Zerwekh, J. E.
    Odvina, C. V.
    Wuermser, L.
    Pak, C. Y.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S436 - S436
  • [2] Bone metabolism and renal stone risk during bed rest for men and women
    Morgan, Jennifer
    Heer, Martina
    Hargens, Allen
    Macias, Brandon
    Hudson, Edgar
    Shackelford, Linda
    Zwart, Sara
    Smith, Scott
    FASEB JOURNAL, 2014, 28 (01):
  • [3] Effect of Potassium Citrate Therapy on the Risk of Renal Stone Formation During Spaceflight
    Whitson, Peggy A.
    Pietrzyk, Robert A.
    Jones, Jeffrey A.
    Nelman-Gonzalez, Mayra
    Hudson, Edgar K.
    Sams, Clarence F.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2490 - 2496
  • [4] Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: A window on renal citrate metabolism
    Tosukhowong, P
    Tungsanga, K
    Phongudom, S
    Sriboonlue, P
    INTERNATIONAL JOURNAL OF UROLOGY, 2005, 12 (02) : 140 - 144
  • [5] Sex-specific responses of bone metabolism and renal stone risk during bed rest
    Morgan, Jennifer L. L.
    Heer, Martina
    Hargens, Alan R.
    Macias, Brandon R.
    Hudson, Edgar K.
    Shackelford, Linda C.
    Zwart, Sara R.
    Smith, Scott M.
    PHYSIOLOGICAL REPORTS, 2014, 2 (08):
  • [6] Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest
    Watanabe, Y
    Ohshima, H
    Mizuno, K
    Sekiguchi, C
    Fukunaga, M
    Kohri, K
    Rittweger, J
    Felsenberg, D
    Matsumoto, T
    Nakamura, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (11) : 1771 - 1778
  • [7] Whey protein with potassium bicarbonate supplement attenuates the reduction in muscle oxidative capacity during 19 days of bed rest
    Bosutti, Alessandra
    Salanova, Michele
    Blottner, Dieter
    Buehlmeier, Judith
    Mulder, Edwin
    Rittweger, Joern
    Yap, Moi Hoon
    Ganse, Bergita
    Degens, Hans
    JOURNAL OF APPLIED PHYSIOLOGY, 2016, 121 (04) : 838 - 848
  • [8] Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise
    Okada, Atsushi
    Ohshima, Hiroshi
    Itoh, Yasunori
    Yasui, Takahiro
    Tozawa, Keiichi
    Kohri, Kenjiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (07) : 630 - 635
  • [9] ENERGY-ABSORPTION, LEAN BODY-MASS, AND TOTAL-BODY FAT CHANGES DURING 5 WEEKS OF CONTINUOUS BED REST
    KREBS, JM
    SCHNEIDER, VS
    EVANS, H
    KUO, MC
    LEBLANC, AD
    AVIATION SPACE AND ENVIRONMENTAL MEDICINE, 1990, 61 (04): : 314 - 318
  • [10] Intra-venous pamidronate infusion prevents bone loss and renal stone formation during 90-day bed rest study.
    Ohshima, H
    Watanabe, Y
    Sekiguchi, C
    Fukunaga, M
    Okada, A
    Kohri, K
    Ohta, H
    Seino, Y
    Takaoka, K
    Esashi, T
    Matsumoto, T
    Nakamura, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S89 - S89